Disease Markers

Disease Markers / 2012 / Article

Open Access

Volume 33 |Article ID 629814 | https://doi.org/10.3233/DMA-2012-00933

Maryam Khojasteh-Fard, Milad Abolhalaj, Parvin Amiri, Majid Zaki, Zahra Taheri, Mostafa Qorbani, Javad Tavakkoly Bazzaz, Mahsa M. Amoli, "IL-23 Gene Expression in PBMCs of Patients with Coronary Artery Disease", Disease Markers, vol. 33, Article ID 629814, 5 pages, 2012. https://doi.org/10.3233/DMA-2012-00933

IL-23 Gene Expression in PBMCs of Patients with Coronary Artery Disease

Received21 Sep 2012
Accepted21 Sep 2012


Objective: Both adaptive and innate immune systems are involved in coronary artery disease (CAD). The aim of this study was to evaluate TH17 cytokines expression profiles in un-stimulated peripheral blood lymphocytes (PBMCs) of patients with coronary artery disease. Methods: Expression profiles of IL-17, IL-23, and TGF-β1 were determined in individuals with and without CAD using Real-time PCR. Results: A significant decrease in IL-23 gene expression in un-stimulated PBMCs of patients with CAD compared to those without CAD was found (p=0.003, OR=0.045, 95% CI: 0.006–0.355). Conclusion: Our data reinforce the potential role of the IL-23 as a critical regulatory molecule that bridges the innate and adaptive arms of the immune system in the complex mechanisms associated with the development of atherosclerosis.

Copyright © 2012 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Order printed copiesOrder

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.